Pure Global

Qualitative DNA Test Kit for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Trichomonas vaginalis - Vietnam Registration 2400209ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative DNA Test Kit for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Trichomonas vaginalis in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400209ĐKLH/BYT-HTTB and manufactured by Seegene, Inc.. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400209ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400209ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative DNA Test Kit for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Trichomonas vaginalis
VN: Bộ xét nghiệm định tính ADN Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum và Trichomonas vaginalis
Risk Class TTBYT Loại C

Registration Details

2400209ĐKLH/BYT-HTTB

000.00.04.G18-211012-0004

Anyplex™ II STI-7e Detection

SD7701X

Company Information

REPUBLIC OF

Technical Details

Qualitative in vitro testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Trichomonas vaginalis from urine samples, swabs (urethral, vaginal and cervical) and cell culture samples in liquid.

Dates and Status

Feb 04, 2024